SANGUI BIOTECH INTERNATIONAL INC Cashflow Statement

Ask AI

Financial Statements

In USD, except per-share amounts

	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021	FY2020 12 months to Jun 30, 2020	FY2019 12 months to Jun 30, 2019	FY2018 12 months to Jun 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Gain on foreign currency exchange transactions
Depreciation and amortization
Common stock issued for services
Common stock issued for out of court settlement
Foreign currency exchange transactions
Loss on settlement of debt
Amortization of right to use asset
Changes in operating assets and liabilities
Trade accounts receivable
Prepaid expenses and other current assets
Tax refunds receivable
Accounts payable and accrued expenses
Related party advances
Related party accounts payable
Operating lease liability
Net Cash Used in Operating Activities

Purchase of equipment
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from related party note payable
Repayment of related party note payable
Proceeds from common stock issued for cash
Repayment of notes payable
Proceeds from note payable
Repayment of note payable
Net Cash Provided by Financing Activities
NET CHANGE IN CASH
EFFECTS OF EXCHANGE RATES ON CASH
NET CHANGES IN CASH
CASH AT BEGINNING OF PERIOD
CASH AT END OF PERIOD
SUPPLEMENTAL CASH FLOW INFORMATION
Interest
Income Taxes
NON - CASH INVESTING AND FINANCING ACTIVITIES
Initial Right of use operating lease assets
Common Stock issued in settlement of liability
Initial Right of operating liabilities
Common Stock issued for settle accounts payables

Comments